Progress

Ongoing development: Atapir has completed three clinical trials — A study in 30 volunteers testing the SpO2 algorithm; a 77 patient study testing the pain monitoring system; and a 130 patient study testing the pain, heart rate, respiratory rate, SpO2, and blood pressure algorithms. Initial results are promising. Results of our pain monitoring study were accepted for publication in the journal Anesthesiology.


Regulatory: Atapir submitted an FDA presubmission application in December for the version 1 system to monitor heart rate, respiratory rate, pain, and fall risk.


Intellectual Property: We continue build and protect our IP.


Atapir wins award: Atapir’s non-contact vital signs monitoring technology garnered significant attention at the recent American Society of Anesthesia (ASA) Annual Meeting in Philadelphia.